Literature DB >> 26715280

Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma.

Woo-Young Sun1, Woo-Hee Jung2, Ja Seung Koo3.   

Abstract

The purpose of this study was to evaluate the association between expression of cancer-associated fibroblast (CAF)-related proteins in papillary thyroid carcinoma (PTC) and clinicopathologic factors. Using tissue microarray (TMA) constructed from 339 cases of PTC (303 classic type, 36 follicular variant), we performed immunohistochemical staining for podoplanin, prolyl 4-hydroxylase, FAPα, S100A4, PDGFRα, PDGFRβ, NG2, 5-meC, and BRAF V600E and evaluated the association with clinicopathologic parameters. We classified the stroma of PTC as desmoplastic type, sclerotic type, pauci type, or inflammatory type. The expression of prolyl 4-hydroxylase (p = 0.042), FAPα (p = 0.044), PDGFRα (p < 0.001), and 5-meC (p = 0.030) in cancer cells differed according to the histologic subtype, higher in classic type than follicular type. The expression of FAPα (p = 0.034) and 5-meC (p = 0.021) in stromal cells was higher in the classic type than follicular type. PTC with BRAF mutation showed higher expression of podoplanin (p < 0.001), prolyl 4-hydroxylase (p = 0.013), FAPα (p < 0.001), S100A4 (p < 0.001), PDGFRα (p < 0.001), and 5-meC (p < 0.001) in the tumor cell compartment and of FAPα (p = 0.004), S100A4 (p < 0.001), PDGFRα (p = 0.002), PDGFRβ (p < 0.001), and 5-meC (p < 0.001) in the stromal cell compartment. There was also a difference in the expression of CAF-related proteins according to stromal phenotype; the expression of FAPα, S100A4, and PDGFRα was higher in desmoplastic type than in other subtypes, whereas NG2 expression was higher in inflammatory type (p < 0.001). Tumoral podoplanin negativity (p = 0.043) was associated with shorter DFS, and tumoral S100A4 positivity (p = 0.044) and stromal PDGFRβ positivity (p = 0.035) were associated with shorter OS. In conclusion, the expression of CAF-related proteins in cancer cells and stromal cells of PTC was different according to histologic subtype, BRAF V600E mutation, and subtype of stroma, and was related to prognosis.

Entities:  

Keywords:  Cancer-associated fibroblast; Papillary carcinoma; Thyroid

Mesh:

Substances:

Year:  2015        PMID: 26715280     DOI: 10.1007/s13277-015-4684-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

Authors:  M Bullock; C O'Neill; A Chou; A Clarkson; T Dodds; C Toon; M Sywak; S B Sidhu; L W Delbridge; B G Robinson; D L Learoyd; D Capper; A von Deimling; R J Clifton-Bligh; A J Gill
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

2.  Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.

Authors:  Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina; Tohru Ikeda
Journal:  Pathol Oncol Res       Date:  2013-11-28       Impact factor: 3.201

3.  Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.

Authors:  Tiffany J Parmenter; Margarete Kleinschmidt; Kathryn M Kinross; Simon T Bond; Jason Li; Mohan R Kaadige; Aparna Rao; Karen E Sheppard; Willy Hugo; Gulietta M Pupo; Richard B Pearson; Sean L McGee; Georgina V Long; Richard A Scolyer; Helen Rizos; Roger S Lo; Carleen Cullinane; Donald E Ayer; Antoni Ribas; Ricky W Johnstone; Rodney J Hicks; Grant A McArthur
Journal:  Cancer Discov       Date:  2014-01-27       Impact factor: 39.397

4.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

5.  Induction of DNA hypomethylation by tumor hypoxia.

Authors:  Siranoush Shahrzad; Kelsey Bertrand; Kanwal Minhas; Brenda L Coomber
Journal:  Epigenetics       Date:  2007-06-14       Impact factor: 4.528

Review 6.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

7.  Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.

Authors:  Akikazu Kawase; Genichiro Ishii; Kanji Nagai; Takeo Ito; Tatsuya Nagano; Yukinori Murata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Kazuya Suzuki; Atsushi Ochiai
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

8.  Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.

Authors:  Jie Zhang; Yuan Wang; Dan Li; Shanghua Jing
Journal:  Tumour Biol       Date:  2013-08-06

9.  Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts.

Authors:  Silke Haubeiss; Jens O Schmid; Thomas E Mürdter; Maike Sonnenberg; Godehard Friedel; Heiko van der Kuip; Walter E Aulitzky
Journal:  Mol Cancer       Date:  2010-06-27       Impact factor: 27.401

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  9 in total

1.  Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.

Authors:  Jae-Gu Cho; Hyung Kwon Byeon; Kyung Ho Oh; Seung-Kuk Baek; Soon-Young Kwon; Kwang-Yoon Jung; Jeong-Soo Woo
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-17       Impact factor: 2.503

2.  PDGFR-β+ fibroblasts deteriorate survival in human solid tumors: a meta-analysis.

Authors:  Guoming Hu; Liming Huang; Kefang Zhong; Liwei Meng; Feng Xu; Shimin Wang; Tao Zhang
Journal:  Aging (Albany NY)       Date:  2021-05-03       Impact factor: 5.682

Review 3.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

Review 4.  Thyroid Cancer and Fibroblasts.

Authors:  Angelica Avagliano; Giuseppe Fiume; Claudio Bellevicine; Giancarlo Troncone; Alessandro Venuta; Vittoria Acampora; Sabrina De Lella; Maria Rosaria Ruocco; Stefania Masone; Nunzio Velotti; Pietro Carotenuto; Massimo Mallardo; Carmen Caiazza; Stefania Montagnani; Alessandro Arcucci
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

5.  The expression of stromal biomarkers in small papillary thyroid carcinomas.

Authors:  Haytham Bayadsi; George Barghout; Moa Gustafsson; Malin Sund; Joakim Hennings
Journal:  World J Surg Oncol       Date:  2022-10-14       Impact factor: 3.253

6.  Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.

Authors:  Erik Kouba; Andrew Ford; Charmaine G Brown; Chen Yeh; Gene P Siegal; Upender Manne; Isam-Eldin Eltoum
Journal:  Am J Clin Pathol       Date:  2018-07-03       Impact factor: 2.493

Review 7.  Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Maria Rosaria Galdiero; Ilaria Ruffilli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Armando Patrizio; Valeria Mazzi; Gilda Varricchi; Gianni Marone; Alessandro Antonelli
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

8.  Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.

Authors:  Emanuela Minna; Silvia Brich; Katia Todoerti; Silvana Pilotti; Paola Collini; Elisa Bonaldi; Paola Romeo; Loris De Cecco; Matteo Dugo; Federica Perrone; Adele Busico; Andrea Vingiani; Ilaria Bersani; Andrea Anichini; Roberta Mortarini; Antonino Neri; Giancarlo Pruneri; Angela Greco; Maria Grazia Borrello
Journal:  Cancers (Basel)       Date:  2020-01-01       Impact factor: 6.639

Review 9.  Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.

Authors:  Myriem Boufraqech; Naris Nilubol
Journal:  Cancers (Basel)       Date:  2019-12-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.